Johnson Matthey (LON:JMAT) Given New GBX 2,100 Price Target at Citigroup

Johnson Matthey (LON:JMAT) had its target price lifted by Citigroup from GBX 1,800 to GBX 2,100 in a research note published on Tuesday, Marketbeat reports. Citigroup currently has a neutral rating on the stock.

Several other equities analysts also recently issued reports on JMAT. Deutsche Bank Aktiengesellschaft upped their target price on Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the company a “buy” rating in a research report on Thursday, October 9th. Berenberg Bank boosted their price target on Johnson Matthey from GBX 1,950 to GBX 2,100 and gave the company a “hold” rating in a research note on Thursday, October 9th. Finally, Jefferies Financial Group raised their price objective on Johnson Matthey from GBX 2,200 to GBX 2,420 and gave the stock a “buy” rating in a research note on Tuesday, October 14th. Two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of GBX 2,230.

Johnson Matthey Stock Down 0.1%

LON:JMAT opened at GBX 2,096 on Tuesday. The company’s 50 day moving average is GBX 1,964 and its two-hundred day moving average is GBX 1,715.59. The company has a market cap of £3.51 billion, a PE ratio of 9.92, a P/E/G ratio of 49,242.50 and a beta of 0.95. Johnson Matthey has a twelve month low of GBX 1,131 and a twelve month high of GBX 2,188. The company has a current ratio of 1.45, a quick ratio of 0.76 and a debt-to-equity ratio of 62.73.

Insider Transactions at Johnson Matthey

In other Johnson Matthey news, insider Andrew Cosslett purchased 10,495 shares of the stock in a transaction on Tuesday, August 26th. The shares were bought at an average cost of GBX 1,896 per share, with a total value of £198,985.20. Insiders have acquired 10,521 shares of company stock worth $19,948,290 in the last three months. Insiders own 0.50% of the company’s stock.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.